Skip to main content

Drug-Induced/Iatrogenic Respiratory Disease: With Emphasis on Unusual, Rare, and Emergent Drug-Induced Reactions

  • Chapter
  • First Online:
Orphan Lung Diseases

Abstract

Drugs have been known to cause adverse respiratory reactions since at least 1880, when Sir William Osler published an autopsy report of a fatal case of opioid-related alveolar edema [1, 2]. Since then, the literature on iatrogenic and drug-induced respiratory disease has expanded to over 30,700 Medline searchable articles. Therapeutic drugs, substances of abuse, contrast media, chemicals (solid, liquid, or gases), solvents, household compounds, waterproofing agents, air conditioner fluid, glue, irradiation, and medical, imaging or surgical procedures can all cause respiratory injury (Tables 42.1 and 42.2). To date, 1650 drugs, chemicals, agents, and procedures (up from 920 listed in the last edition of this chapter) can cause injury in the form of any of the 784 clinical, imaging, bronchoalveolar, and histopathologic patterns of involvement identified so far. Since 1997, drugs, patterns of injury, and the specific literature are indexed in Pneumotox, a set of daily updated web service and Apps [3, 4] (Table 42.3, Figs. 42.1, 42.2, 42.3, 42.4, 42.5, and 42.6).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Osler W. Oedema of the left lung - morphia poisoning. Montreal general hospital reports clinical and pathological, vol. 1. Montreal, QC: M Dawson Bros Publishers; 1880. p. 291–2.

    Google Scholar 

  2. Sternbach G. William Osler: narcotic-induced pulmonary edema. J Emerg Med. 1983;1:165–7.

    Article  CAS  PubMed  Google Scholar 

  3. Pneumotox. II (V2.2) Website: 2018. Producer: Ph Camus: Last update: April 19, 2022. 2018. https://www.pneumotox.com.

  4. Pneumotox. Pneumotox-App: Pneumotox II (V2.2-mobile) App: 2019. Producer: Ph Camus: Last update: April 18, 2022; 2019.

    Google Scholar 

  5. Hill AB. The environment and disease: association or causation? Proc R Soc Med. 1965;58:295–300.

    CAS  PubMed  PubMed Central  Google Scholar 

  6. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239–45.

    Article  CAS  PubMed  Google Scholar 

  7. Felip E, Llobera L, Perez-Mañá C, Quintela D, Guasch I, Margelí M, Teruel I, Cirauqui B, Centeno C, Romeo M, Ballana E, Quiroga V. New drugs, old toxicities: pneumonitis related to palbociclib - a case report. Breast Care. 2020;15:548–52.

    Article  PubMed  Google Scholar 

  8. Cardiotox. Cardiotox-App: Cardiotox (V1.0-mobile) App: 2021. Producer: Ph Camus: Last update: April 19, 2022; 2021.

    Google Scholar 

  9. Miller JO, Shih AR, Mino-Kenudson M, Taylor MS, Goldman JL. Trimethoprim-sulfamethoxazole-associated fulminant respiratory failure in children and young adults. Am J Respir Crit Care Med. 2021;203:918–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Sears CR, Peikert T, Possick JD, Naidoo J, Nishino M, Patel SP, Camus P, Gaga M, Garon EB, Gould MK, Limper AH, Montgrain PR, Travis WD, Rivera MP. Knowledge gaps and research priorities in immune checkpoint inhibitor-related pneumonitis. An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med. 2019;200:e31–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Spagnolo P, Bonniaud P, Rossi G, Sverzellati N, Cottin V. Drug-induced interstitial lung disease. Eur Respir J. 2022;

    Google Scholar 

  12. Hayes D Jr, Board A, Calfee C, Ellington S, Pollack LA, Kathuria H, Eakin MN, Weissman DN, Callahan SJ, Esper AM, Crotty Alexander LE, Sharma NS, Meyer NJ, Smith LS, Novosad S, Evans ME, Goodman AB, Click ES, Robinson RT, Ewart G, et al. Pulmonary and critical care considerations for e-cigarette, or vaping, product use-associated lung injury (EVALI). Chest. 2022;162:256.

    Article  PubMed  Google Scholar 

  13. Wolfe F, Michaud K, Anderson J, Urbansky K. Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy. Arthritis Rheum. 2004;50:372–9.

    Article  CAS  PubMed  Google Scholar 

  14. Wakeman SE. Opioid use disorder diagnosis and management. N Engl J Med Evid. 2022;1:1.

    Google Scholar 

  15. Vujaklija Brajković A, Grgat M, Bielen L, Brajković J, Zlopaša O, Vrdoljak NG, Radonić R. Self-poisoning as a cause of admission in a medical intensive care unit and a question of misuse of prescription medications. Heart Lung. 2021;51:17–21.

    Article  PubMed  Google Scholar 

  16. Ciottone GR. Toxidrome recognition in chemical-weapons attacks. N Engl J Med. 2018;378:1611–20.

    Article  CAS  PubMed  Google Scholar 

  17. Chai PR, Hayes BD, Erickson TB, Boyer EW. Novichok agents: a historical, current, and toxicological perspective. Toxicol Commun. 2018;2:45–8.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Henretig FM, Kirk MA, McKay CA Jr. Hazardous chemical emergencies and poisonings. N Engl J Med. 2019;380:1638–55.

    Article  CAS  PubMed  Google Scholar 

  19. Dart RC, Goldfrank LR, Erstad BL, Huang DT, Todd KH, Weitz J, Bebarta VS, Caravati EM, Henretig FM, Delbridge TR, Banner W, Schneider SM, Anderson VE. Expert consensus guidelines for stocking of antidotes in hospitals that provide emergency care. Ann Emerg Med. 2018;71:314–325.e1.

    Article  PubMed  Google Scholar 

  20. Upadhyaya VD, Douedi S, Akula M, Chalasani KK, Saybolt MD, Hossain M. Amiodarone-induced thyroid storm causing sustained monomorphic ventricular tachycardia treated with plasmapheresis: a challenging clinical case. J Med Cases. 2020;11:79–81.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Abrams JL, Fermi D, Belligund P, McFarlane SI. Amiodarone-induced hypothyroidism related to pericardial effusion with tamponade physiology. Cureus. 2022;14:e22932.

    PubMed  PubMed Central  Google Scholar 

  22. André MC, Hammer J. Life-threatening accidental intravenous epinephrine overdose in a 12-year-old boy. Pediatr Emerg Care. 2018;35:e110–2.

    Google Scholar 

  23. Haleem Z, Gradon JD. Radiographic Evolution of Presumed Septic Pulmonary Emboli. N Engl J Med. 2022;386:1452.

    Article  PubMed  Google Scholar 

  24. Kummer RL, Kempainen RR, Olives TD, Leatherman JW, Prekker ME. Naloxone-associated pulmonary edema following recreational opioid overdose: a case series. Am J Emerg Med. 2021;53:41–3.

    Article  PubMed  Google Scholar 

  25. Case B, Oszko MA. Use of an algorithm to evaluate published reports of adverse drug reactions. Am J Hosp Pharm. 1991;48:121–2.

    CAS  PubMed  Google Scholar 

  26. Naranjo CA, Lanctot KL. Recent developments in computer-assisted diagnosis of putative adverse drug reactions. Drug Saf. 1991;6:315–22.

    Article  CAS  PubMed  Google Scholar 

  27. Koyama N, Iwase O, Nakashima E, Kishida K, Kondo T, Watanabe Y, Takahashi H, Umebayashi Y, Ogawa Y, Miura H. High incidence and early onset of nivolumab-induced pneumonitis: four case reports and literature review. BMC Pulm Med. 2018;18:23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Pozzessere C, Bouchaab H, Jumeau R, Letovanec I, Daccord C, Bourhis J, Prior JO, Peters S, Lazor R, Beigelman-Aubry C. Relationship between pneumonitis induced by immune checkpoint inhibitors and the underlying parenchymal status: a retrospective study. ERJ Open Res. 2020;6:00165.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Johkoh T, Lee KS, Nishino M, Travis WD, Ryu JH, Lee HY, Ryerson CJ, Franquet T, Bankier AA, Brown KK, Goo JM, Kauczor HU, Lynch DA, Nicholson AG, Richeldi L, Schaefer-Prokop CM, Verschakelen J, Raoof S, Rubin GD, Powell C, et al. Chest CT diagnosis and clinical management of drug-related pneumonitis in patients receiving molecular targeting agents and immune checkpoint inhibitors: a position paper from the Fleischner Society. Radiology. 2021;298:550–66.

    Article  PubMed  Google Scholar 

  30. Johkoh T, Lee KS, Nishino M, Travis WD, Ryu JH, Lee HY, Ryerson CJ, Franquet T, Bankier AA, Brown KK, Goo JM, Kauczor HU, Lynch DA, Nicholson AG, Richeldi L, Schaefer-Prokop CM, Verschakelen J, Raoof S, Rubin GD, Powell C, et al. Chest CT diagnosis and clinical management of drug-related pneumonitis in patients receiving molecular targeting agents and immune checkpoint inhibitors: a position paper from the Fleischner Society. Chest. 2021;159:1107–25.

    Article  CAS  PubMed  Google Scholar 

  31. Cleverley JR, Screaton NJ, Hiorns MP, Flint JD, Müller NL. Drug-induced lung disease: high-resolution CT and histological findings. Clin Radiol. 2002;57:292–9.

    Article  PubMed  Google Scholar 

  32. Yoneda KY, Shelton DK, Beckett LA, Gandara DR. Independent review of interstitial lung disease associated with death in TRIBUTE (paclitaxel and carboplatin with or without concurrent erlotinib) in advanced non-small cell lung cancer. J Thorac Oncol. 2007;2:537–43.

    Article  PubMed  Google Scholar 

  33. Hansell DM, Bankier AA, MacMahon H, McLoud TC, Müller NL, Rémy J. Fleischner Society: glossary of terms tor thoracic imaging. Radiology. 2008;246:697–722.

    Article  PubMed  Google Scholar 

  34. Thomeer M, Demedts M, Vandeurzen K. Registration of interstitial lung diseases by 20 centres of respiratory medicine in Flanders. Acta Clin Belg. 2001;56:163–72.

    Article  CAS  PubMed  Google Scholar 

  35. Dhokarh R, Li G, Schmickl CN, Kashyap R, Assudani J, Limper AH, Gajic O. Drug associated acute lung injury: a population based cohort study. Chest. 2012;142:845–50.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Rabe C, Appenrodt B, Hoff C, Ewig S, Klehr HU, Sauerbruch T, Nickenig G, Tasci S. Severe respiratory failure due to diffuse alveolar hemorrhage: clinical characteristics and outcome of intensive care. J Crit Care. 2009;25:230–5.

    Article  PubMed  Google Scholar 

  37. De Giacomi F, Decker PA, Vassallo R, Ryu JH. Acute eosinophilic pneumonia: correlation of clinical characteristics with underlying cause. Chest. 2017;152:379–85.

    Article  PubMed  Google Scholar 

  38. Barroso E, Hernandez L, Gil J, Garcia R, Aranda I, Romero S. Idiopathic organizing pneumonia: a relapsing disease. 19 years of experience in a hospital setting. Respiration. 2007;74:624–31.

    Article  PubMed  Google Scholar 

  39. Drakopanagiotakis F, Paschalaki K, Abu-Hijleh M, Aswad B, Karagianidis N, Kastanakis E, Braman SS, Polychronopoulos V. Cryptogenic and secondary organizing pneumonia: clinical presentation, radiographic findings, treatment response and prognosis. Chest. 2011;139:893–900.

    Article  PubMed  Google Scholar 

  40. Epler GR, Kelly EM. Post-breast cancer radiotherapy bronchiolitis obliterans organizing pneumonia. Respir Care. 2020;65:686–92.

    Article  PubMed  Google Scholar 

  41. O’Driscoll BR, Kalra S, Gattamaneni HR, Woodcock AA. Late carmustine lung fibrosis. Age at treatment may influence severity and survival. Chest. 1995;107:1355–7.

    PubMed  Google Scholar 

  42. Dixon DL, Dunn SP, Kelly MS, McLlarky TR, Brown RE. Effectiveness of pharmacist-led amiodarone monitoring services on improving adherence to amiodarone monitoring recommendations: a systematic review. Pharmacotherapy. 2016;36:230–6.

    Article  PubMed  Google Scholar 

  43. Hotta T, Okimoto T, Hamaguchi M, Tsubata Y, Isobe T. Acute interstitial lung disease induced by rechallenge with ceritinib. Intern Med. 2020;59:253–6.

    Article  PubMed  Google Scholar 

  44. Kwok WC, Ma TF, Chan JWM, Pang HH, Ho JCM. A multicenter retrospective cohort study on predicting the risk for amiodarone pulmonary toxicity. BMC Pulm Med. 2022;22:128–37.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Chen X, Li Z, Wang X, Zhou J, Wei Q, Jiang R. Association of pre-existing lung interstitial changes with immune-related pneumonitis in patients with non-small lung cancer receiving immunotherapy. Support Care Cancer. 2022;30:6515.

    Article  PubMed  Google Scholar 

  46. Bristedt P, Tylén U. Pulmonary edema following intravenous injection of nonionic low-osmolar contrast medium - appearance on HRCT - a case report. Acta Radiol. 1998;39:81–3.

    CAS  PubMed  Google Scholar 

  47. Picado C, Castillo JA, Montserrat JM, Agusti-Vidal A. Aspirin-intolerance as a precipitating factor of life-threatening attacks of asthma requiring mechanical ventilation. Eur Respir J. 1989;2:127–9.

    Article  CAS  PubMed  Google Scholar 

  48. Bojanini L, Morgenstern-Kaplan D, Carrillo-Martin I, Vanegas YAM, Cuervo-Pardo L, Zwiener R, Gonzalez-Estrada A. Chemotherapy-induced anaphylaxis and fatal anaphylaxis in the United States: incidence and risk factors. Clin Exp Allergy. 2021;51:1514–8.

    Article  PubMed  Google Scholar 

  49. Skolnik A, Monas J. The crashing toxicology patient. Emerg Med Clin North Am. 2020;38:841–56.

    Article  PubMed  Google Scholar 

  50. Kiyatkin EA. Respiratory depression and brain hypoxia induced by opioid drugs: morphine, oxycodone, heroin, and fentanyl. Neuropharmacology. 2019;151:219–26.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Vater LB, Lefebvre B, Turk A, Clasen SC. Fluoropyrimidine cardiotoxicity: incidence, outcomes, and safety of rechallenge. Curr Oncol Rep. 2022;24:943.

    Article  CAS  PubMed  Google Scholar 

  52. Anderson RP, Zechar K. Lung injury from inhaling butane hash oil mimics pneumonia. Respir Med Case Rep. 2019;26:171–3.

    PubMed  PubMed Central  Google Scholar 

  53. Bauer-Kemény C, Kreuter M. [Addictive inhalants - a challenge for the lungs]. Pneumologe (Berl). 2022;19:49–59.

    Google Scholar 

  54. Okie S. A flood of opioids, a rising tide of deaths. N Engl J Med. 2010;363:1981–5.

    Article  CAS  PubMed  Google Scholar 

  55. Lineberry TW, Bostwick JM. Taking the physician out of “physician shopping”: a case series of clinical problems associated with Internet purchases of medication. Mayo Clin Proc. 2004;79:1031–4.

    Article  PubMed  Google Scholar 

  56. Gilbert CR, Baram M, Cavarocchi NC. “Smoking wet”: respiratory failure related to smoking tainted marijuana cigarettes. Tex Heart Inst J. 2013;40:64–7.

    PubMed  PubMed Central  Google Scholar 

  57. Lineberry TW, Bostwick JM. Methamphetamine abuse: a perfect storm of complications. Mayo Clin Proc. 2006;81:77–84.

    Article  PubMed  Google Scholar 

  58. Koppen A, Wijnands-Kleukers APG, Gresnigt FMJ, de Lange DW. Clinical toxicology of exposures to chemicals from clandestine drug laboratories: a literature review. Clin Toxicol. 2022;60:559–70.

    Article  CAS  Google Scholar 

  59. Valverde-Monge M, Fernandez-Nieto M, Lopez VB, Rodrigo-Munoz JM, Canas JA, Sastre B, Garcia Del Potro M, De Las Heras M, Pozo VD, Sastre J. Novel causes of drug-induced occupational asthma. J Allergy Clin Immunol Pract. 2019;7:740–2.

    Article  PubMed  Google Scholar 

  60. Leslie KO. My approach to interstitial lung disease using clinical, radiological and histopathological patterns. J Clin Pathol. 2009;62:387–401.

    Article  CAS  PubMed  Google Scholar 

  61. Roden AC, Camus P. Iatrogenic pulmonary lesions. Semin Diagn Pathol. 2018;35:260–71.

    Article  PubMed  Google Scholar 

  62. Moui A, Dirou S, Sagan C, Liberge R, Defrance C, Arrigoni PP, Morla O, Kandel-Aznar C, Cellerin L, Cavailles A, Eschapasse E, Morio F, Gourraud PA, Goronflot T, Tissot A, Blanc FX. Immune alveolitis in interstitial lung disease: an attractive cytological profile in immunocompromised patients. BMC Pulm Med. 2022;22:79.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Koo LC, Clark JA, Quesenberry CP, Higenbottam T, Nyberg F, Wolf MK, Steinberg MH, Forsythe BH. National differences in reporting ‘pneumonia’ and ‘pneumonia interstitial’: an analysis of the WHO International Drug Monitoring Database on 15 drugs in nine countries for seven pulmonary conditions. Pharmacoepidemiol Drug Saf. 2005;14:775–87.

    Article  PubMed  Google Scholar 

  64. Dorr DA, Burdon R, West DP, Lagman J, Georgopoulos C, Belknap SM, McKoy JM, Djulbegovic B, Edwards BJ, Weitzman SA, Boyle S, Tallman MS, Talpaz M, Sartor O, Bennett CL. Quality of reporting of serious adverse drug events to an institutional review board: a case study with the novel cancer agent, imatinib mesylate. Clin Cancer Res. 2009;15:3850–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Transport-Accident-Investigation-Commission. Aviation inquiry AO-2018-006 Robinson R44, ZK-HTB Loss of control Stevensons Arm, Lake Wanaka 21 July 2018 September 2020. Wellington: Transport; 2020. 52 p.

    Google Scholar 

  66. Rodriguez-Reyes M, Marco-Hernandez J, Castro-Rebollo P, Soy-Muner D. Interstitial pneumonitis and myelosuppression associated to mitomycin C urinary tract instillations: a case report. J Oncol Pharm Pract. 2019;25:739–42.

    Article  CAS  PubMed  Google Scholar 

  67. Matson SM, Demoruelle MK, Castro M. Airway disease in rheumatoid arthritis. Ann Am Thorac Soc. 2022;19:343–52.

    Article  PubMed  PubMed Central  Google Scholar 

  68. Montani D, Seferian A, Savale L, Simonneau G, Humbert M. Drug-induced pulmonary arterial hypertension: a recent outbreak. Eur Respir Rev. 2013;22:244–50.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Savale L, Chaumais MC, Cottin V, Bergot E, Frachon I, Prevot G, Pison C, Dromer C, Poubeau P, Lamblin N, Habib G, Reynaud-Gaubert M, Bourdin A, Sanchez O, Tubert-Bitter P, Jais X, Montani D, Sitbon O, Simonneau G, Humbert M. Pulmonary hypertension associated with benfluorex exposure. Eur Respir J. 2012;40:1164–72.

    Article  PubMed  Google Scholar 

  70. Myers JL. Diagnosis of drug reactions in the lung. Monogr Pathol. 1993;36:32–53.

    Google Scholar 

  71. Myers JL, Limper AH, Swensen SJ. Drug-induced lung disease: a pragmatic classification incorporating HRCT appearances. Semin Respir Crit Care Med. 2003;24:445–54.

    Article  PubMed  Google Scholar 

  72. Camus P, Colby TV, Rosenow ECI. Amiodarone pulmonary toxicity. In: Camus P, Rosenow EC, editors. Drug-induced and iatrogenic lung disease. London: Hodder Arnold; 2010.

    Chapter  Google Scholar 

  73. Jennane S, Haidouri S, Zine Filali K, Ahchouch S, Mahtat E M, Doghmi K, Mikdame M. [Fatal bleomycin induced pneumomediastinum and bilateral pneumothorax]. Rev Pneumol Clin. 2017;73:153–6.

    Google Scholar 

  74. Jansson PS, Leisten DC, Sarkisian TM, Wilcox SR, Lee J. Recurrent hydrochlorothiazide-induced acute respiratory distress syndrome treated with extracorporeal membrane oxygenation. J Emerg Med. 2018;55:836–40.

    Article  PubMed  Google Scholar 

  75. Dinis-Oliveira RJ, Carvalho F, Duarte JA, Proenca JB, Santos A, Magalhaes T. Clinical and forensic signs related to cocaine abuse. Curr Drug Abuse Rev. 2012;5:64–83.

    Article  CAS  PubMed  Google Scholar 

  76. Taskinen E, Tukainen P, Sovijärvi ARA. Nitrofurantoin-induced alterations in pulmonary tissue. A report on five patients with acute or subacute reactions. Acta Pathol Microbiol Scand A. 1977;85:713–20.

    CAS  PubMed  Google Scholar 

  77. Milne EN, Pistolesi M, Miniati M, Giuntini C. The radiologic distinction of cardiogenic and noncardiogenic edema. AJR Am J Roentgenol. 1985;144:879–94.

    Article  CAS  PubMed  Google Scholar 

  78. Maldonado M, Villamin CE, Murphy LE, Dasgupta A, Bassett RL, Correa Medina M, Bates TS, Martinez F, Knopfelmacher Couchonal AM, Klein K, Kelley JM. Oncology patients who develop transfusion-associated circulatory overload: an observational study. Lab Med. 2022;53:344.

    Article  PubMed  PubMed Central  Google Scholar 

  79. Megarbane B, Chevillard L. The large spectrum of pulmonary complications following illicit drug use: features and mechanisms. Chem Biol Interact. 2013;206:444–51.

    Article  CAS  PubMed  Google Scholar 

  80. Jehn U, Göldel N, Rienmüller R, Wilmanns W. Non-cardiogenic pulmonary edema complicating intermediate and high-dose Ara C treatment for relapsed acute leukemia. Med Oncol Tumor Pharmacother. 1988;5:41–7.

    Article  CAS  PubMed  Google Scholar 

  81. Glisson JK, Vesa TS, Bowling MR. Current management of salicylate-induced pulmonary edema. South Med J. 2011;104:225–32.

    Article  PubMed  Google Scholar 

  82. Toy P, Looney MR, Popovsky M, Palfi M, Berlin G, Chapman CE, Bolton-Maggs P, Matthay MA. Transfusion-related acute lung injury: 36 years of progress (1985-2021). Ann Am Thorac Soc. 2022;19:705.

    Article  PubMed  Google Scholar 

  83. Lipshultz SE, Cochran TR, Franco VI, Miller TL. Treatment-related cardiotoxicity in survivors of childhood cancer. Nat Rev Clin Oncol. 2013;10:697–710.

    Article  CAS  PubMed  Google Scholar 

  84. McCormick BJ, Kuhlman J, Chirila RM. 54-Year-old man with acute dyspnea on exertion. Mayo Clin Proc. 2022;97(5):1008–13.

    Article  PubMed  Google Scholar 

  85. de Wall C, Bauersachs J, Berliner D. Cardiooncology-dealing with modern drug treatment, long-term complications, and cancer survivorship. Clin Exp Metastasis. 2021;38:361–71.

    Article  PubMed  PubMed Central  Google Scholar 

  86. Sridhar S, Kanne JP, Henry TS, Revels JW, Gotway MB, Ketai LH. Medication-induced pulmonary injury: a scenario- and pattern-based approach to a perplexing problem. Radiographics. 2022;42:38–55.

    Article  PubMed  Google Scholar 

  87. Rivera MP, Detterbeck FC, Socinski MA, Moore DT, Edelman MJ, Jahan TM, Ansari RH, Luketich JD, Peng G, Monberg M, Obasaju CK, Gralla RJ. Impact of preoperative chemotherapy on pulmonary function tests in resectable early-stage non-small cell lung cancer. Chest. 2009;135:1588–95.

    Article  PubMed  Google Scholar 

  88. Simpson AB, Paul J, Graham J, Kaye SB. Fatal bleomycin pulmonary toxicity in the west of Scotland 1991-95: a review of patients with germ cell tumours. Br J Cancer. 1998;78:1061–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  89. Warren K, Vu K, Shergill K, Watson B, Faris M. Rare complication of a commonly used antihypertensive agent: a case of hydralazine-induced ANCA-associated vasculitis presenting as rapidly progressive glomerulonephritis. Clin Case Rep. 2022;10:e05411.

    Article  PubMed  PubMed Central  Google Scholar 

  90. Kamijo Y, Sato C, Yoshimura K, Soma K. Notable pink excreta and severe myocardial suppression in superwarfarin (difethialone) intoxication. Intern Med. 2011;50:2819–22.

    Article  CAS  PubMed  Google Scholar 

  91. Caravati EM, Erdman AR, Scharman EJ, Woolf AD, Chyka PA, Cobaugh DJ, Wax PM, Manoguerra AS, Christianson G, Nelson LS, Olson KR, Booze LL, Troutman WG. Long-acting anticoagulant rodenticide poisoning: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol. 2007;45:1–22.

    Article  CAS  Google Scholar 

  92. Schmid A, Tzur A, Leshko L, Krieger BP. Silicone embolism syndrome. A case report, review of the literature, and comparison with fat embolism syndrome. Chest. 2005;127:2276–81.

    Article  PubMed  Google Scholar 

  93. Lewin-Smith M, Kalasinsky V, Shilo K, Tomashefski J, Cropp A. Detection of silicone in lung tissue. Arch Pathol Lab Med. 2012;136:1179–80.

    Article  PubMed  Google Scholar 

  94. Choi HK, Slot MC, Pan GL, Weissbach CA, Niles JL, Merkel PA. Evaluation of antineutrophil cytoplasmic antibody seroconversion induced by minocycline, sulfasalazine, or penicillamine. Arthritis Rheum. 2000;43:2488–92.

    Article  CAS  PubMed  Google Scholar 

  95. Choi HK, Merkel PA, Walker AM, Niles JL. Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies. Arthritis Rheum. 2000;43:405–13.

    Article  CAS  PubMed  Google Scholar 

  96. Russe-Russe JR, Pellegrini JR Jr, Alvarez-Betancourt A, Munshi RF, Anand P. Fulminant anti-neutrophil cytoplasmic antibody-associated vasculitis after 10 years of hydralazine use. Cureus. 2021;13:e18974.

    PubMed  PubMed Central  Google Scholar 

  97. Lazor R, Bigay-Game L, Cottin V, Cadranel J, Decaux O, Fellrath JM, Cordier JF. Alveolar hemorrhage in anti-basement membrane antibody disease: a series of 28 cases. Medicine (Baltimore). 2007;86:181–93.

    Article  PubMed  Google Scholar 

  98. Murphy CE, Kenny CM, Brown KF. TACO and TRALI: visualising transfusion lung injury on plain film. BMJ Case Rep. 2020;13:e230426.

    Article  PubMed  PubMed Central  Google Scholar 

  99. Van Ness M, Jensen H, Adamson GN, Kysar PE, Holland P. Neutrophils contain cholesterol crystals in Transfusion-Related Acute Lung Injury (TRALI). Am J Clin Pathol. 2013;140:170–6.

    Article  PubMed  Google Scholar 

  100. Kopko PM, Marshall CS, MacKenzie MR, Holland PV, Popovsky MA. Transfusion-related acute lung injury. Report of a clinical look-back investigation. JAMA. 2002;287:1968–71.

    Article  PubMed  Google Scholar 

  101. Vossoughi S, Gorlin J, Kessler DA, Hillyer CD, Van Buren NL, Jimenez A, Shaz BH. Ten years of TRALI mitigation: measuring our progress. Transfusion. 2019;59:2567.

    Article  PubMed  Google Scholar 

  102. Tomari S, Homma K, Noguchi T, Aiba T, Matsuki T, Suzuki R, Koga M, Takigami M, Tagawa H, Hashimoto T, Toyoda K. Development of interstitial lung disease after initiation of apixaban anticoagulation therapy. J Stroke Cerebrovasc Dis. 2016;25:1767–9.

    Article  PubMed  Google Scholar 

  103. Ghincea A, Ryu C, Herzog EL. An acute exacerbation of idiopathic pulmonary fibrosis after BNT162b2 mRNA COVID-19 vaccination: a case report. Chest. 2022;161:e71–3.

    Article  CAS  PubMed  Google Scholar 

  104. Sgalla G, Magrì T, Lerede M, Comes A, Richeldi L. COVID-19 vaccine in patients with exacerbation of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2022;206:219.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  105. Fuhrman C, Parrot A, Wislez M, Prigent H, Boussaud V, Bernaudin JF, Mayaud C, Cadranel J. Spectrum of CD4 to CD8 T-cell ratios in lymphocytic alveolitis associated with methotrexate-induced pneumonitis. Am J Respir Crit Care Med. 2001;164:1186–91.

    Article  CAS  PubMed  Google Scholar 

  106. Blackwell TS, Gossage JR. Gold pulmonary toxicity in a patient with a normal chest radiograph. South Med J. 1995;88:644–6.

    Article  CAS  PubMed  Google Scholar 

  107. Ashida C, Kinoshita K, Nozaki Y, Funauchi M. Fatal outcome in a patient under immunosuppressant therapy infected with human T-lymphotropic virus type 1 (HTLV-1), cytomegalovirus (CMV) and Strongyloides stercoralis: a case report. BMC Infect Dis. 2020;20:470.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  108. Tazelaar HD, Linz LJ, Colby TV, Myers JL, Limper AH. Acute eosinophilic pneumonia: histopathologic findings in nine patients. Am J Respir Crit Care Med. 1997;155:296–302.

    Article  CAS  PubMed  Google Scholar 

  109. Nasim F, Paul JA, Boland-Froemming J, Wylam ME. Sulfa-induced acute eosinophilic pneumonia. Respir Med Case Rep. 2021;34:101496.

    PubMed  PubMed Central  Google Scholar 

  110. Hauser T, Mahr A, Metzler C, Coste J, Sommerstein R, Gross WL, Guillevin L, Hellmich B. The leucotriene receptor antagonist montelukast and the risk of Churg-Strauss syndrome: a case-crossover study. Thorax. 2008;63:677–82.

    Article  CAS  PubMed  Google Scholar 

  111. Bibby S, Healy B, Steele R, Kumareswaran K, Nelson H, Beasley R. Association between leukotriene receptor antagonist therapy and Churg-Strauss syndrome: an analysis of the FDA AERS database. Thorax. 2010;65:132–8.

    Article  CAS  PubMed  Google Scholar 

  112. Miedema J, Nunes H. Drug-induced sarcoidosis-like reactions. Curr Opin Pulm Med. 2021;27:439–47.

    Article  CAS  PubMed  Google Scholar 

  113. Mukhopadhyay S. Role of histology in the diagnosis of infectious causes of granulomatous lung disease. Curr Opin Pulm Med. 2011;17:189–96.

    Article  PubMed  Google Scholar 

  114. Aydogan Eroglu S, Yildiz T, Sonkaya E, Kavas M, Ozbaki F, Sertçelik L, Sen A, Sevim T. Diagnosis distribution in cases with granulomatous inflammation in lung, pleura, and lymph node biopsies: an experience from a tertiary level single center chest diseases and thoracic surgery hospital. Sarcoidosis Vasc Diffuse Lung Dis. 2022;38:e2021048.

    PubMed  Google Scholar 

  115. Mukhopadhyay S, Wilcox BE, Myers JL, Bryant SC, Buckwalter SP, Wengenack NL, Yi ES, Aughenbaugh GL, Specks U, Aubry MC. Pulmonary necrotizing granulomas of unknown cause: clinical and pathologic analysis of 131 patients with completely resected nodules. Chest. 2013;144:813–24.

    Article  PubMed  Google Scholar 

  116. Imokawa S, Colby TV, Leslie KO, Helmers RA. Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients. Eur Respir J. 2000;15:373–81.

    Article  CAS  PubMed  Google Scholar 

  117. Cottin V, Bendstrup E, Bonniaud P, Nasser M, Spagnolo P, Valenzuela C, Kolb M. The case of methotrexate and the lung: Dr Jekyll and Mr Hyde. Eur Respir J. 2021;57:2100079.

    Article  PubMed  Google Scholar 

  118. Kremer JM, Alarcon GS, Weinblatt ME, Kaymakcian MV, Macaluso M, Cannon GW, Palmer WR, Sundy JS, St Clair EW, Alexander RW, Walker-Smith GJ, Axiotis CA. Clinical, laboratory, radiographic, and histopathologic features of methotrexate-associated lung injury in patients with rheumatoid arthritis. Arthritis Rheum. 1997;40:1829–37.

    Article  CAS  PubMed  Google Scholar 

  119. Notghi AAA, Hosseini F, Tsogas N. Severe diffuse proliferative bronchiolitis complicating culture-proven disseminated BCG infection after intravesical instillation for bladder cancer. BMJ Case Rep. 2022;15:e248681.

    Article  PubMed  Google Scholar 

  120. Hofland RW, Thijsen SF, Verhagen MA, Schenk Y, Bossink AW. Tuberculosis during TNF-alpha inhibitor therapy, despite screening. Thorax. 2013;68:1079–80.

    Article  PubMed  Google Scholar 

  121. Hossein-Zadeh Z, Shuman MJ, Rapkiewicz A. Fatal excipients: an autopsy case series of excipient lung disease. Am J Forensic Med Pathol. 2022;43:81–9.

    Article  PubMed  Google Scholar 

  122. Westphalen SS, Torres FS, Tonetto MS, Zampieri JF, Torri GB, Garcia TS. Interobserver agreement regarding the Fleischner Society diagnostic criteria for usual interstitial pneumonia patterns on computed tomography. Radiol Bras. 2022;55:71–7.

    Article  PubMed  PubMed Central  Google Scholar 

  123. Conte P, Ascierto PA, Patelli G, Danesi R, Vanzulli A, Sandomenico F, Tarsia P, Cattelan A, Comes A, De Laurentiis M, Falcone A, Regge D, Richeldi L, Siena S. Drug-induced interstitial lung disease during cancer therapies: expert opinion on diagnosis and treatment. ESMO Open. 2022;7:100404.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  124. Beasley MB, Franks TJ, Galvin JR, Gochuico B, Travis WD. Acute fibrinous and organizing pneumonia. A histologic pattern of lung injury and possible variant of diffuse alveolar damage. Arch Pathol Lab Med. 2002;126:1064–70.

    Article  PubMed  Google Scholar 

  125. Karnatovskaia LV, Festic E, Gajic O, Carter RE, Lee AS. Prehospital amiodarone may increase the incidence of acute respiratory distress syndrome among patients at risk. J Crit Care. 2012;27:447–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  126. van Mieghem W, Coolen L, Malysse I, Lacquet LM, Deneffe GJD, Demedts MGP. Amiodarone and the development of ARDS after lung surgery. Chest. 1994;105:1642–5.

    Article  PubMed  Google Scholar 

  127. Saussine M, Colson P, Alauzen M, Mary H. Postoperative acute respiratory distress syndrome. A complication of amiodarone associated with 100 percent oxygen ventilation. Chest. 1992;102:980–1.

    Article  CAS  PubMed  Google Scholar 

  128. Larsen BT, Vaszar LT, Colby TV, Tazelaar HD. Lymphoid hyperplasia and eosinophilic pneumonia as histologic manifestations of amiodarone-induced lung toxicity. Am J Surg Pathol. 2012;36:509–16.

    Article  PubMed  Google Scholar 

  129. Affleck A, Goudie A, Smith R. Fatal, incidental, idiopathic pulmonary fibrosis in a patient receiving long-term low-dose methotrexate for psoriasis. Clin Exp Dermatol. 2019;44:591–2.

    Article  CAS  PubMed  Google Scholar 

  130. Al Nokhatha SA, Harrington R, Conway R. Is methotrexate contra-indicated in lung involvement of rheumatoid arthritis? Joint Bone Spine. 2020;87:535–7.

    Article  PubMed  Google Scholar 

  131. Juge PA, Lee JS, Lau J, Kawano-Dourado L, Rojas Serrano J, Sebastiani M, Koduri G, Matteson E, Bonfiglioli K, Sawamura M, Kairalla R, Cavagna L, Bozzalla Cassione E, Manfredi A, Mejia M, Rodríguez-Henriquez P, González-Pérez MI, Falfán-Valencia R, Buendia-Roldán I, Pérez-Rubio G, et al. Methotrexate and rheumatoid arthritis associated interstitial lung disease. Eur Respir J. 2021;57:2000337.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  132. Certain MC, Georges M, Beltramo G, Schenesse D, Mouillot P, Tankéré P, Bonniaud P. Adalimumab-induced interstitial pneumonia in patients with inflammatory bowel disease. Respir Med Res. 2020;78:100790.

    PubMed  Google Scholar 

  133. Schuller A, Coudurier M, Lega JC, Khouatra C, Cottin V, Cordier JF. Interstitial lung disease and anti-TNF-alpha therapy in rheumatoid arthritis: two different patterns? Rev Mal Respir. 2010;27:232–7.

    Article  CAS  PubMed  Google Scholar 

  134. Wolfe F, Caplan L, Michaud K. Rheumatoid arthritis treatment and the risk of severe interstitial lung disease. Scand J Rheumatol. 2007;36:172–8.

    Article  CAS  PubMed  Google Scholar 

  135. Hagiwara K, Sato T, Takagi Kobayashi S, Hasegawa S, Shigihara N, Akiyama O. Acute exacerbation of preexisting interstitial lung disease after administration of etanercept for rheumatoid arthritis. J Rheumatol. 2007;34:1151–4.

    PubMed  Google Scholar 

  136. Dixon WG, Hyrich KL, Watson KD, Lunt M, Symmons DP. Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics Register. Ann Rheum Dis. 2010;69:1086–91.

    Article  CAS  PubMed  Google Scholar 

  137. Cohen JV, Capell BC, Kinniry PA, Epstein AL. Rapidly fatal pulmonary fibrosis in a patient with psoriatic arthritis treated with adalimumab. J Rheumatol. 2011;38:398–9.

    Article  PubMed  Google Scholar 

  138. Curtis JR, Sarsour K, Napalkov P, Costa LA, Schulman KL. Incidence and complications of interstitial lung disease in users of tocilizumab, rituximab, abatacept and anti-tumor necrosis factor alpha agents, a retrospective cohort study. Arthritis Res Ther. 2015;17:319.

    Article  PubMed  PubMed Central  Google Scholar 

  139. Parambil JG, Myers JL, Aubry MC, Ryu JH. Causes and prognosis of diffuse alveolar damage diagnosed on surgical lung biopsy. Chest. 2007;132:50–7.

    Article  PubMed  Google Scholar 

  140. Saravanan V, Kelly CA. Reducing the risk of methotrexate pneumonitis in rheumatoid arthritis. Rheumatology (Oxford). 2004;43:143–7.

    Article  CAS  PubMed  Google Scholar 

  141. Dawson JK, Quah E, Earnshaw B, Amoasii C, Mudawi T, Spencer LG. Does methotrexate cause progressive fibrotic interstitial lung disease? A systematic review. Rheumatol Int. 2021;41:1055–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  142. Ueno T, Ohta T, Sugio Y, Ohno Y, Uehara Y. Severe acute interstitial lung disease after BNT162b2 mRNA COVID-19 vaccination in a patient post HLA-haploidentical hematopoietic stem cell transplantation. Bone Marrow Transplant. 2022;57:1–3.

    Article  Google Scholar 

  143. The-International-Collaborative-Study-of-Severe-Anaphylaxis. Risk of anaphylaxis in a hospital population in relation to the use of various drugs: an international study. Pharmacoepidemiol Drug Saf. 2003;12:195–202.

    Article  Google Scholar 

  144. Hyeon CW, Lee JY, Jang S, Cho SI, Kim S, Lee W, Shin S. Medical malpractice related to drug-induced anaphylaxis: an analysis of lawsuit judgments in South Korea. Medicine (Baltimore). 2019;98:e15996.

    Article  PubMed  Google Scholar 

  145. Lieberman PL. Recognition and first-line treatment of anaphylaxis. Am J Med. 2014;127:S6–11.

    Article  PubMed  Google Scholar 

  146. Pumphrey RSH. Lessons from management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy. 2000;30:1144–50.

    Article  CAS  PubMed  Google Scholar 

  147. Pumphrey RS, Stanworth SJ. The clinical spectrum of anaphylaxis in north-west England. Clin Exp Allergy. 1996;26:1364–70.

    Article  CAS  PubMed  Google Scholar 

  148. Muraro A, Worm M, Alviani C, Cardona V, DunnGalvin A, Garvey LH, Riggioni C, de Silva D, Angier E, Arasi S, Bellou A, Beyer K, Bijlhout D, Bilò MB, Bindslev-Jensen C, Brockow K, Fernandez-Rivas M, Halken S, Jensen B, Khaleva E, et al. EAACI guidelines: anaphylaxis (2021 update). Allergy. 2022;77:357–77.

    Article  PubMed  Google Scholar 

  149. Barni S, Mori F, Giovannini M, de Luca M, Novembre E. In situ simulation in the management of anaphylaxis in a pediatric emergency department. Intern Emerg Med. 2019;14:127–32.

    Article  PubMed  Google Scholar 

  150. Ulusoy OL, Kahraman S, Karalok I, Kaya E, Enercan M, Sever C, Abay B, Karadereler S, Hamzaoglu A. Pulmonary cement embolism following cement-augmented fenestrated pedicle screw fixation in adult spinal deformity patients with severe osteoporosis (analysis of 2978 fenestrated screws). Eur Spine J. 2018;27:2348–56.

    Article  PubMed  Google Scholar 

  151. Oshinsky C, Bhavani S, Funaki A. Cement cardiac embolism following kyphoplasty noted on thoracic imaging. Radiol Case Rep. 2018;13:914–6.

    Article  PubMed  PubMed Central  Google Scholar 

  152. Jouneau S, Vauléon E, Caulet-Maugendre S, Polard E, Volatron A-C, Meunier C, Tattevin P, Montani D, Garin E, Raoul J-L, Delaval P. 131I-labeled lipiodol-induced interstitial pneumonia: a series of 15 cases. Chest. 2010;139:1463–9.

    Article  PubMed  Google Scholar 

  153. Esposito M, Montana A, Liberto A, Filetti V, Nunno ND, Amico F, Salerno M, Loreto C, Sessa F. Anaphylactic death: a new forensic workflow for diagnosis. Healthcare. 2021;9:117–32.

    Article  PubMed  PubMed Central  Google Scholar 

  154. Weisman DS, Arnouk N, Asghar MB, Qureshi MR, Kumar A, Desale S, Camire L, Pineda S. ACE inhibitor angioedema: characterization and treatment versus non-ACE angioedema in acute hospitalized patients. J Commun Hosp Intern Med Perspect. 2020;10:16–8.

    Article  Google Scholar 

  155. Wilkerson RG, Winters ME. Angiotensin-converting enzyme inhibitor-induced angioedema. Emerg Med Clin North Am. 2022;40:79–98.

    Article  PubMed  Google Scholar 

  156. Jackeviciute J, Pilvinis V, Pilviniene R. Fatal outcome of late-onset angiotensin-converting enzyme inhibitor induced angioedema: a case report. Medicine (Baltimore). 2018;97:e11695.

    Article  PubMed  Google Scholar 

  157. Rasmussen ER, Bygum A. ACE-inhibitor induced angio-oedema treated with complement C1-inhibitor concentrate. BMJ Case Rep. 2013;2013:bcr2013200652.

    Article  PubMed  PubMed Central  Google Scholar 

  158. Depetri F, Tedeschi A, Cugno M. Angioedema and emergency medicine: from pathophysiology to diagnosis and treatment. Eur J Intern Med. 2019;59:8–13.

    Article  CAS  PubMed  Google Scholar 

  159. Brown NJ, Snowden M, Griffin MR. Recurrent angiotensin-converting enzyme inhibitor-associated angioedema. JAMA. 1997;278:232–3.

    Article  CAS  PubMed  Google Scholar 

  160. Foucher P, Merati M, Baudouin N, Reybet-Degat O, Camus P, Jeannin L. Fatal ball-valve airway obstruction by an extensive blood clot during mechanical ventilation. Eur Respir J. 1996;9:2181–2.

    Article  CAS  PubMed  Google Scholar 

  161. Sethia R, Bishop R, Gordian-Arroyo A, Matrka L. Iron pill-induced chemical laryngitis. Ann Otol Rhinol Laryngol. 2022;34894221075115

    Google Scholar 

  162. Lee P, Culver DA, Farver C, Mehta AC. Syndrome of iron pill aspiration. Chest. 2002;121:1355–7.

    Article  PubMed  Google Scholar 

  163. Küpeli E, Khemasuwan D, Lee P, Mehta AC. “Pills” and the air passages. Chest. 2013;144:651–60.

    Article  PubMed  Google Scholar 

  164. Kupeli E, Khemasuwan D, Tunsupon P, Mehta AC. “Pills” and the air passages: a continuum. Chest. 2015;147:242–50.

    Article  PubMed  Google Scholar 

  165. Picado C. Classification of severe asthma exacerbations: a proposal. Eur Respir J. 1996;9:1775–8.

    Article  CAS  PubMed  Google Scholar 

  166. Fallowfield JM, Marlow HF. Propranolol is contraindicated in asthma. Br Med J. 1996;313:1486.

    Article  CAS  Google Scholar 

  167. Spitz DJ. An unusual death in an asthmatic patient. Am J Forensic Med Pathol. 2003;24:271–2.

    Article  PubMed  Google Scholar 

  168. Ridley-Smith RM. A fatal error. N Z Med J. 2007;120:U2570.

    PubMed  Google Scholar 

  169. Bennett M, Chang CL, Tatley M, Savage R, Hancox RJ. The safety of cardioselective β(1)-blockers in asthma: literature review and search of global pharmacovigilance safety reports. ERJ Open Res. 2021;7:00801–2020.

    Article  PubMed  PubMed Central  Google Scholar 

  170. Levine M, Iliescu ME, Margellos-Anast H, Estarziau M, Ansell DA. The effects of cocaine and heroin use on intubation rates and hospital utilization in patients with acute asthma exacerbations. Chest. 2005;128:1951–7.

    Article  PubMed  Google Scholar 

  171. Krantz AJ, Hershow RC, Prachand N, Hayden DM, Franklin C, Hryhorczuk DO. Heroin insufflation as a trigger for patients with life-threatening asthma. Chest. 2003;123:510–7.

    Article  PubMed  Google Scholar 

  172. Grant-Alfieri A, Schaechter J, Lipshultz SE. Ingesting and aspirating dry cinnamon by children and adolescents: the “cinnamon challenge”. Pediatrics. 2013;131:833–5.

    Article  PubMed  PubMed Central  Google Scholar 

  173. Barbara DW, Ronan KP, Maddox DE, Warner MA. Perioperative angioedema: background, diagnosis, and management. J Clin Anesth. 2013;25:335.

    Article  PubMed  Google Scholar 

  174. Percy MJ, McFerran NV, Lappin TR. Disorders of oxidised haemoglobin. Blood Rev. 2005;19:61–8.

    Article  CAS  PubMed  Google Scholar 

  175. Lefevre T, Nuzzo A, Megarbane B. Poppers-induced life-threatening methemoglobinemia. Am J Respir Crit Care Med. 2018;198:e137–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  176. Brown C, Bowling M. Methemoglobinemia in bronchoscopy: a case series and a review of the literature. J Bronchol Interv Pulmonol. 2013;20:241–6.

    Article  Google Scholar 

  177. Ingrassia TSI, Ryu JH, Trastek VF, Rosenow ECI. Oxygen-exacerbated bleomycin pulmonary toxicity. Mayo Clin Proc. 1991;66:173–8.

    Article  PubMed  Google Scholar 

  178. Connolly S, Hountras P. A 49-Year-old woman with chest pain, cough, and hypoxemia after a seizure. Chest. 2019;155:e113–6.

    Article  PubMed  Google Scholar 

  179. West JB. Fragility of pulmonary capillaries. J Appl Physiol. 2013;115:1–15.

    Article  PubMed  Google Scholar 

  180. Willms D, Shure D. Pulmonary edema due to upper airway obstruction in adults. Chest. 1988;94:1090–2.

    Article  CAS  PubMed  Google Scholar 

  181. Gondouin A, Manzoni P, Ranfaing E, Brun J, Cadranel J, Sadoun D, Cordier JF, Depierre A, Dalphin JC. Exogenous lipid pneumonia: a retrospective multicentre study of 44 cases in France. Eur Respir J. 1996;9:1463–9.

    Article  CAS  PubMed  Google Scholar 

  182. Chouri N, Langin T, Lantuejoul S, Coulomb M, Brambilla C. Pulmonary nodules with the CT halo sign. Respiration. 2002;69:103–6.

    Article  PubMed  Google Scholar 

  183. Ruangchira-Urai R, Colby TV, Klein J, Nielsen GP, Kradin RL, Mark EJ. Nodular amiodarone lung disease. Am J Surg Pathol. 2008;32:1654–60.

    Article  PubMed  Google Scholar 

  184. von der Thüsen JH, Hansell DM, Tominaga M, Veys PA, Ashworth MT, Owens CM, Nicholson AG. Pleuroparenchymal fibroelastosis in patients with pulmonary disease secondary to bone marrow transplantation. Mod Pathol. 2011;24:1633–9.

    Article  PubMed  Google Scholar 

  185. von der Thüsen JH. Pleuroparenchymal fibroelastosis: its pathological characteristics. Curr Respir Med Rev. 2013;9:238–47.

    Article  PubMed  PubMed Central  Google Scholar 

  186. Camus P, von der Thusen J, Hansell DM, Colby TV. Pleuroparenchymal fibroelastosis: one more walk on the wild side of drugs? Eur Respir J. 2014;44:289–96.

    Article  PubMed  Google Scholar 

  187. Rodrigues Vieira AC, Monteiro Ferra JR, Vicente De Carvalho JS, Melo N, Caetano Mota P, Novais EBH, Pereira JM, Souto Moura C, Morais A. Pleuroparenchymal fibroelastosis as a complication of chemotherapy: a case report. Mol. Clin Oncol. 2022;16:71.

    Google Scholar 

  188. Beynat-Mouterde C, Beltramo G, Lezmi G, Pernet D, Camus C, Fanton A, Foucher P, Cottin V, Bonniaud P. Pleuroparenchymal fibroelastosis as a late complication of chemotherapy agents. Eur Respir J. 2014;44:523–7.

    Article  PubMed  Google Scholar 

  189. Ni Chroinin D, Gaine S. Cracking the case: a patient with persistent delirium due to body packing with cocaine. Ir Med J. 2012;105:118–9.

    CAS  PubMed  Google Scholar 

  190. Manzella A, Filho PB, Albuquerque E, Farias F, Kaercher J. Imaging of gossypibomas: pictorial review. AJR Am J Roentgenol. 2009;193:S94–101.

    Article  PubMed  Google Scholar 

  191. Nemati MH. Mediastinal gossypiboma simulating a malignant tumour. Interact Cardiovasc Thorac Surg. 2012;15:783–5.

    Article  PubMed  PubMed Central  Google Scholar 

  192. Yilmaz Durmaz D, Yilmaz BK, Yildiz O, Bas Y. A rare cause of chronic cough: intrathoracic gossypiboma. Iran J Radiol. 2014;11:e13933.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Bonniaud, P., Camus, P. (2023). Drug-Induced/Iatrogenic Respiratory Disease: With Emphasis on Unusual, Rare, and Emergent Drug-Induced Reactions. In: Cottin, V., Richeldi, L., Brown, K., McCormack, F.X. (eds) Orphan Lung Diseases. Springer, Cham. https://doi.org/10.1007/978-3-031-12950-6_42

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-12950-6_42

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-12949-0

  • Online ISBN: 978-3-031-12950-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics